While Phase 3 trial of RTB101 for respiratory illness did not meet primary endpoint, company presses-on with Parkinson’s trial for TORC1 inhibitor: Results expected...
AI start-up NetraMark targets $3 million seed round while identifying that an exciting repurposing candidate has potential for indication expansion into Longevity.
“I won’t tell you...
New proteomic discoveries reveal a link between levels of certain proteins in human plasma and aging.
The field of aging-targeting therapeutics is rapidly evolving. The...
Partnership sees AI platform expanded into drug repurposing and discovery.
Canadian AI technology firm NetraMark yesterday announced the extension of its NetraPharma collaboration agreement with...
A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society.
The world is...
Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...
BIOFABICS brings custom design tools to biofabrication.
While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...
